Carina C. D. Joe

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Amy Flaxman, Natalie G. Marchevsky, Daniel Jenkin et al. · The Lancet · 2021 · 253 citations · Full text

Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs

Carina C. D. Joe, Jinlin Jiang, Thomas Linke et al. · Biotechnology and Bioengineering · 2021 · 63 citations · Full text

Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity

Carina C. D. Joe, Sayantani Chatterjee, George O. Lovrecz et al. · Vaccine · 2020 · 41 citations

Vaccination, Enhanced Immunogenicity, Viral Hepatitis +7